These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 33814834)

  • 1. Low Cost, Low Dose, Oral, Neoadjuvant Chemotherapy Protocol in Locally Advanced Borderline Oral Cancers-Feasibility Study.
    Sultania M; Deo SVS; Shukla NK; Sharma A; Sahoo R; Bhasker S
    Indian J Surg Oncol; 2021 Mar; 12(1):67-72. PubMed ID: 33814834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metronomic Therapy in Palliation of Oral Cancer Patients-A Home Based Approach at the End of Life.
    Sultania M; Imaduddin M; Muduly DK; Majumdar SKD; Adhya AK; Parida DK; Kar M
    Gulf J Oncolog; 2022 Sep; 1(40):24-28. PubMed ID: 36448067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of metronomic therapy for advanced oral cancers and predictors of response: Multi-institutional feasibility study.
    Sultania M; Imaduddin M; S V Deo S; Kar M; K Muduly D; Kumar S; Sharma A; Mishra A; K D Majumdar S; K Adhya A; K Parida D
    Head Neck; 2022 Jan; 44(1):104-112. PubMed ID: 34708450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial.
    Patil V; Noronha V; Dhumal SB; Joshi A; Menon N; Bhattacharjee A; Kulkarni S; Ankathi SK; Mahajan A; Sable N; Nawale K; Bhelekar A; Mukadam S; Chandrasekharan A; Das S; Vallathol D; D'Souza H; Kumar A; Agrawal A; Khaddar S; Rathnasamy N; Shenoy R; Kashyap L; Rai RK; Abraham G; Saha S; Majumdar S; Karuvandan N; Simha V; Babu V; Elamarthi P; Rajpurohit A; Kumar KAP; Srikanth A; Ravind R; Banavali S; Prabhash K
    Lancet Glob Health; 2020 Sep; 8(9):e1213-e1222. PubMed ID: 32827483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB-C, BRAF
    Long GV; Saw RPM; Lo S; Nieweg OE; Shannon KF; Gonzalez M; Guminski A; Lee JH; Lee H; Ferguson PM; Rawson RV; Wilmott JS; Thompson JF; Kefford RF; Ch'ng S; Stretch JR; Emmett L; Kapoor R; Rizos H; Spillane AJ; Scolyer RA; Menzies AM
    Lancet Oncol; 2019 Jul; 20(7):961-971. PubMed ID: 31171444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral metronomic chemotherapy as a feasible preoperative therapy in advanced resectable oral cavity squamous cell carcinomas- a preliminary experience.
    Shenoy VPPK; Manuprasad A; Babu S; Aravind S; Narayanan VN; Nayanar S; Balasubramanian S
    Ecancermedicalscience; 2022; 16():1425. PubMed ID: 36158988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trial.
    Hu H; Kang L; Zhang J; Wu Z; Wang H; Huang M; Lan P; Wu X; Wang C; Cao W; Hu J; Huang Y; Huang L; Wang H; Shi L; Cai Y; Shen C; Ling J; Xie X; Cai Y; He X; Dou R; Zhou J; Ma T; Zhang X; Luo S; Deng W; Ling L; Liu H; Deng Y
    Lancet Gastroenterol Hepatol; 2022 Jan; 7(1):38-48. PubMed ID: 34688374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I/II Study of Palliative Triple Metronomic Chemotherapy in Platinum-Refractory/Early-Failure Oral Cancer.
    Patil VM; Noronha V; Joshi A; Dhumal S; Mahimkar M; Bhattacharjee A; Gota V; Pandey M; Menon N; Mahajan A; Sable N; Kumar S; Nawale K; Mukadam S; Solanki B; Das S; Simha V; Abraham G; Chandrasekharan A; Talreja V; DSouza H; Srinivas S; Kashyap L; Banavali S; Prabhash K
    J Clin Oncol; 2019 Nov; 37(32):3032-3041. PubMed ID: 31539316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative Chemotherapy and Metronomic Scheduling of Chemotherapy in Locally Advanced Oral Cancers.
    Patil VM; Noronha V; Joshi A; Banavali SD; Muddu V; Prabhash K
    Oncology; 2016; 91 Suppl 1():35-40. PubMed ID: 27463093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to approach pancreatic cancer after neoadjuvant treatment: assessment of resectability using multidetector CT and tumor markers.
    Jeon SK; Lee JM; Lee ES; Yu MH; Joo I; Yoon JH; Jang JY; Lee KB; Lee SH
    Eur Radiol; 2022 Jan; 32(1):56-66. PubMed ID: 34170366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy followed by concurrent chemoradiation for locally advanced nasopharyngeal carcinoma.
    Kong L; Zhang YW; Hu CS; Guo Y
    Chin J Cancer; 2010 May; 29(5):551-5. PubMed ID: 20426907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant irinotecan, cisplatin, and concurrent radiation therapy with celecoxib for patients with locally advanced esophageal cancer.
    Cleary JM; Mamon HJ; Szymonifka J; Bueno R; Choi N; Donahue DM; Fidias PM; Gaissert HA; Jaklitsch MT; Kulke MH; Lynch TP; Mentzer SJ; Meyerhardt JA; Swanson RS; Wain J; Fuchs CS; Enzinger PC
    BMC Cancer; 2016 Jul; 16():468. PubMed ID: 27412386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metronomic chemotherapy in the neoadjuvant setting: results of two parallel feasibility trials (TraQme and TAME) in patients with HER2+ and HER2- locally advanced breast cancer.
    Petry V; Gagliato DM; Leal AI; Arai RJ; Longo E; Andrade F; Ricci MD; Piato JR; Barroso-Sousa R; Hoff PM; Mano MS
    Braz J Med Biol Res; 2015 May; 48(5):479-85. PubMed ID: 25760024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of neoadjuvant chemotherapy (NACT) with paclitaxel plus carboplatin and oral metronomic chemotherapy (OMCT) in patients with technically unresectable oral squamous cell carcinoma (OSCC).
    Kashyap L; Patil V; Noronha V; Joshi A; Menon N; Jobanputra K; Saha S; Chaturvedi P; Banavali SD; Prabhash K
    Ecancermedicalscience; 2021; 15():1325. PubMed ID: 35211194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot phase II study of neoadjuvant triplet chemotherapy regimen in patients with locally advanced resectable colon cancer.
    Zhou H; Song Y; Jiang J; Niu H; Zhao H; Liang J; Su H; Wang Z; Zhou Z; Huang J
    Chin J Cancer Res; 2016 Dec; 28(6):598-605. PubMed ID: 28174488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial.
    Provencio M; Nadal E; Insa A; García-Campelo MR; Casal-Rubio J; Dómine M; Majem M; Rodríguez-Abreu D; Martínez-Martí A; De Castro Carpeño J; Cobo M; López Vivanco G; Del Barco E; Bernabé Caro R; Viñolas N; Barneto Aranda I; Viteri S; Pereira E; Royuela A; Casarrubios M; Salas Antón C; Parra ER; Wistuba I; Calvo V; Laza-Briviesca R; Romero A; Massuti B; Cruz-Bermúdez A
    Lancet Oncol; 2020 Nov; 21(11):1413-1422. PubMed ID: 32979984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High rate of clinical complete response to weekly outpatient neoadjuvant chemotherapy in oral carcinoma patients using a new regimen of cisplatin, 5-fluorouracil, and bleomycin alternating with methotrexate and epirubicin.
    Lin JC; Jan JS; Hsu CY; Wong DY
    Cancer; 1999 Apr; 85(7):1430-8. PubMed ID: 10193931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvage therapy with oral metronomic cyclophosphamide and methotrexate for castration-refractory metastatic adenocarcinoma of the prostate resistant to docetaxel.
    Gebbia V; Serretta V; Borsellino N; Valerio MR;
    Urology; 2011 Nov; 78(5):1125-30. PubMed ID: 22054386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metronomic chemotherapy in advanced oral cancers.
    Patil V; Noronha V; D'cruz AK; Banavali SD; Prabhash K
    J Cancer Res Ther; 2012 Jan; 8 Suppl 1():S106-10. PubMed ID: 22322727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The protocol of a prospective, multicenter, randomized, controlled phase III study evaluating different cycles of oxaliplatin combined with S-1 (SOX) as neoadjuvant chemotherapy for patients with locally advanced gastric cancer: RESONANCE-II trial.
    Wang X; Li S; Sun Y; Li K; Shen X; Xue Y; Liang P; Li G; Chen L; Zhao Q; Li G; Fu W; Liang H; Xin H; Suo J; Fang X; Zheng Z; Xu Z; Chen H; Zhou Y; He Y; Huang H; Zhu L; Yang K; Ji J; Ye Y; Zhang Z; Li F; Wang X; Tian Y; Park S; Chen L
    BMC Cancer; 2021 Jan; 21(1):20. PubMed ID: 33402102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.